Colorectal Cancer Resource & Action Network
@ccranorg
Followers
595
Following
539
Media
859
Statuses
2K
CCRAN is the most trusted colorectal cancer resource & action network in Canada. It's our mission to provide support, education, & advocacy.
Toronto, ON
Joined May 2021
The session recordings from 2025 My Colorectal Cancer Coach Summit are now live!. #ColorectalCancer #CancerCoaching #PatientSupport #CaregiverSupport #CancerEducation #CancerAwareness #CancerCommunity #ColorectalCancerCare #CancerResources #CancerSupport
0
0
1
A huge thank you to our sponsors, our patient advocacy group partners and the team at CCRAN for an amazing conference!.
0
0
1
There is a significant need to increase awareness about CGP nationally. Targeted educational initiatives for both patients and clinicians are essential and continued research to improve the effectiveness and affordability of CGP is required. - Filomena Servidio-Italiano, CCRAN.
0
0
0
A great session! @GenomeAlberta.
Public-private partnerships (P3s) can accelerate innovation, bring care models to market faster, align stakeholder priorities, de-risk early research, enhance knowledge translation, improve outcomes, and foster shared expertise across sectors.- Gijs van Rooijen
0
0
0
Effective conflict-of-interest management in P3s requires clear boundaries: transparent goals, defined evaluation criteria, and safeguards at the program level to prevent undue influence and ensuring public interest .- Étienne Richer @GenomeCanada.
0
1
0
Public-private partnerships (P3s) can accelerate innovation, bring care models to market faster, align stakeholder priorities, de-risk early research, enhance knowledge translation, improve outcomes, and foster shared expertise across sectors.- Gijs van Rooijen
0
0
0
Future directions in radioligand therapy include using diverse therapeutic isotopes and shifting from monotherapy to combination approaches to target different pathways for synergistic benefit in oncology. - Dr. David Laidley.
0
0
0
Dr. David Laidley speaks on the future of Radioligand therapies in Canada at the #2025BiomarkersConference
1
0
0
LIVE NOW!.The Value of Partnerships to Drive Innovation in Health Care Systems. This virtual conference is free. #CCRAN #ColorectalCancer #SupportEducationAdvocacy #CancerAwareness #JoinTheFight #PatientAdvocacy #HealthForAll #CancerResearch
0
0
0
As patient partners, it is essential to stay informed about how these tools are developed and used. Ensuring the data is representative of all patient populations. - Cham Srinivasan (Caregiver).
0
0
0
LIVE NOW!.Coming in ‘Hot’: The Future of Radioligand Therapies in Canada. This virtual conference is free. #CancerSurvivorship #OncologyCare #CancerTreatment #CancerPatients #CancerCare #CancerAdvocates #CancerWarriors #CancerPrioritySetting
0
0
0
We need a high bar for how AI is used in cancer care. It’s a powerful tool, but not without limits. From prevention & screening to treatment selection and scheduling, AI will shape every step of the cancer care continuum. - Dr. Omar Khan.
0
0
0
We are looking to predict patients’ survival through CT scan images at the time of diagnosis. From the images alone, we can see muscle content, fat content and fluids. This is one of the benefits of AI .- Dr. Omar Khan.
1
0
0
A patient should have their genome sequenced as early as possible, ideally at the point of diagnosis. It’s a battle against time. The earlier you receive results, the better positioned you are to enter a clinical trial when the time comes. - Megan Mahoney.
0
0
0
LIVE NOW!. Innovative AI Based Technology in the Management of Metastatic Cancer. This virtual conference is free. #CCRAN #ColorectalCancer #SupportEducationAdvocacy #CancerAwareness #JoinTheFight #CancerPrioritySetting #HealthAdvocacy
0
0
0
How much is too much information? We aim to offer hope while setting realistic expectations. Every doctor wants to do their best, but time constraints, provider shortages, and limited resources demand new ways to deliver meaningful care. - Dr. Michael Raphael.
0
0
0
Doctors need to develop relationships with patients and share as much information as they can, on alternate therapies. When this is missing, the patient loses trust in the healthcare system. - Nora Woo (Caregiver).
0
0
0
CGP is here to stay. Learning that we can monitor restistance and identify mutations to avoid progression is positive information for both clinicians and patients. - Dr. Thejus Jayakrishnan.
0
0
0
Liquid biopsies serve as a guide to understand disease burden and we can use that information to tailor treatment. - Dr. Shantanu Banerji #2025BiomarkersConference.
0
0
0